Based on our Pharmacor advisory service entitled Prostate Cancer, Decision Resources is offering an exclusive analyst call entitled Turbulent Times in the Prostate Cancer Drug Market – What Are the Commercial Implications of Recent Events? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.

Recorded live on Wednesday, October 20, 2010


This 15-minute analyst call, presented by Analyst Andrew Merron, Ph.D., answers the following questions:

• In light of recent events in this space, what are the commercial implications for the overall prostate cancer drug market?
• What are the most important clinical results for prostate cancer that were released from the 2010 annual ESMO conference?
• Through 2019, which emerging prostate cancer therapies are expected to launch?
• What are the market dynamics in terms of drug class and drug-treatable population segments? 

Contact us to learn how you can purchase this service and access a recorded download of this event.

Click here to view the invite.